Hoegaarden, Belgium

Ulf Tilstam

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Context Biopharma Inc., Bayer Pharma Aktiengesellschaft. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulf Tilstam. Retrieved from https://idiyas.com/inventor/ulf-tilstam-dzu20xx8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ulf Tilstam: Innovator in Onapristone Synthesis

Introduction

Ulf Tilstam is a notable inventor based in Hoegaarden, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of onapristone. With a total of 3 patents to his name, Tilstam's work has advanced the methodologies used in drug development.

Latest Patents

Tilstam's latest patents include innovative methods for the synthesis of onapristone. One of his patents focuses on the dehydration and deprotection of onapristone synthesis, utilizing acidic hydrolysis and dehydration with sulfuric acid in an alcoholic solution. Another patent details methods for creating intermediates in the synthesis of onapristone, which includes the photoconversion of these intermediates using a narrow band frequency light source.

Career Highlights

Throughout his career, Ulf Tilstam has worked with prominent companies in the pharmaceutical industry. He has been associated with Context Biopharma Inc. and Bayer Pharma Aktiengesellschaft, where he has contributed to various projects aimed at enhancing drug synthesis processes.

Collaborations

Tilstam has collaborated with several professionals in his field, including Stefan Proniuk and Holger Bindernagel. These collaborations have further enriched his research and development efforts.

Conclusion

Ulf Tilstam's innovative work in the synthesis of onapristone has positioned him as a key figure in pharmaceutical chemistry. His patents and collaborations reflect his commitment to advancing drug development methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…